FindTrial
Sign In

vacuum assisted biopsy to see response after chemotherapy in breast cancer.

To assess the accuracy of vacuum assisted biopsy (VAB)to determine the pathological complete response following NACT in breast cancer patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093065
Enrollment
30
Registered
2025-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Vaccum assisted biopsy: USG guided biopsy prior to surgery. 2 weeks post surgery Control Intervention1: Standard surgical procedure: standard surgical procedure will be performed as per

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.female patients more than 18 years old 2.patients having T1,T2& T3 with N0 breast cancer having complete response on contrast enhanced mammography following chemotherapy. 3.patients having unifocal disease prior to chemotherapy 4.patients in whom breast localization clip has been placed.

Exclusion criteria

Exclusion criteria: 1.Patients having clinical or radiological positive lymph node status. 2.patients having extensive microcalcification on initial mammography 3.patients having multifocal or multicentric breast cancer 4.patients in which position of clip is too far posterior or too superficial thus making it difficult to complete VAB

Design outcomes

Primary

MeasureTime frame
concordance of vab pathology with surgical histopathology.Timepoint: Two weeks post surgery—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactAyush Khajuria

AIIMS delhi

krithikarangarajan@aiims.edu01129575064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026